Envestnet Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
NIMC
WC
RA
HA
WC
ICOM
Envestnet Asset Management's LFCR Position: Q3 2018 in Review
Envestnet Asset Management sold out of Lifecore Biomedical (LFCR) in Q3 2018, closing a stake of 1,690 shares — an estimated $25K sold.
Envestnet Asset Management first reported a position in LFCR in Q2 2013 and held it in 18 quarters. The position peaked at $54K in Q3 2015. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2018.
- Envestnet Asset Management reported no remaining Lifecore Biomedical position as of Q3 2018 after selling out during the quarter.
- Envestnet Asset Management sold 1,690 Lifecore Biomedical shares in Q3 2018, an estimated $25K.
- Envestnet Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 18 quarters.
- Envestnet Asset Management's Lifecore Biomedical position peaked at $54K in Q3 2015.
- 90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2018.
Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.